Hannah Pymont

Hannah Pymont
Public Health England | HPA · Public Health Laboratory Bristol

MSc Clinical Science (Infection Sciences)

About

2
Publications
726
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
760
Citations
Citations since 2017
2 Research Items
760 Citations
20172018201920202021202220230100200300
20172018201920202021202220230100200300
20172018201920202021202220230100200300
20172018201920202021202220230100200300
Introduction
Trainee Clinical Scientist (STP) Microbiology 2018-2021. Working within Public Health England (National Infection Service). Currently involved in COVID-19 Pandemic Response and member of the COG-UK Consortium. Graduated from University of Bristol with MSc Biomedical Sciences Research (Distinction).
Additional affiliations
September 2018 - present
Public Health England
Position
  • Researcher
Description
  • Sample logistics and metadata coordinator for COG-UK project at Bristol Public Health Laboratory. Assisting in investigations of local outbreaks and validation of in house and commercial assays for SARS-CoV-2.
April 2015 - September 2015
University of Bristol
Position
  • Master's Student
Description
  • Investigating antimicrobial resistance in gonococci.
September 2014 - September 2015
University of Bristol
Position
  • Master's Student
Education
September 2018 - July 2021
Queen Mary, University of London
Field of study
  • Clinical Science (Infection Sciences)
September 2014 - September 2015
University of Bristol
Field of study
  • Biomedical Sciences Research
September 2006 - July 2007
University of Wales Trinity Saint David
Field of study
  • Secondary Biology with Science

Publications

Publications (2)
Preprint
Full-text available
There is widespread interest in the capacity for SARS-CoV-2 evolution in the face of selective pressures from host immunity, either naturally acquired post-exposure or from vaccine acquired immunity. Allied to this is the potential for long perm persistent infections within immune compromised individuals to allow a broader range of viral evolution...
Article
Full-text available
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G are suggestive of a selective advantage but may also be due to a random founder effect. We investigate the hypothesis for positive selection of spike D614G in the United Kingdom using more than 25,000 whole genome SARS-CoV-2 sequences. Despite the availability o...

Network

Cited By